SIX · BSLN.SW
Basilea Pharmaceutica AG
CHF 71.20-CHF 0.30 (-0.42%)
Basilea Pharmaceutica AG’s quoted price sits in the upper half of its reported 52-week range, 6.07% below the high.
Loading market information…
OTC · YIHCF · USD
Stock price, dividends, earnings
Quote as of Aug 5, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.’s forward annual dividend is $0.03 per share, paid semi-annual. The forward yield is 5.33% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow YiChang HEC ChangJiang Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise primarily engaged in the development, manufacturing, and distribution of medicinal products. Operating within the People's Republic of China, its therapeutic expertise spans antiviral treatments, solutions for endocrine and metabolic disorders, and cardiovascular health. In addition to finished pharmaceuticals, the company produces and markets active pharmaceutical ingredients (APIs) and dedicates resources to the research and development of medical devices, novel drugs, and biotechnology. It also extends its services to include medical consulting. The company's products reach hospitals and other healthcare institutions through an established network of distributors. YiChang HEC ChangJiang Pharmaceutical has forged strategic alliances with several prominent entities, including a cooperation framework agreement with Alibaba Health Technology (China) Limited for specialized influenza projects. Other key partners encompass Jointown Pharmaceutical Group Co., Ltd., Guangdong Yihao Pharmaceutical Co., Ltd., Shenzhen HEC Industrial Development Co., Ltd., and China National Accord Medicines Corporation Ltd. Founded in Yichang, China, in 2001, the company was originally known as Yichang Changjiang Pharmaceutical Company Limited before its rebranding to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. It operates as a subsidiary under the umbrella of Guangdong HEC Technology Holding Co., Ltd.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:36 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CHF 71.20-CHF 0.30 (-0.42%)
Basilea Pharmaceutica AG’s quoted price sits in the upper half of its reported 52-week range, 6.07% below the high.
$24.57$0.00 (0.0%)
Torii Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 100.0% below the high.
CA$7.05-CA$0.23 (-3.16%)
Verano Holdings Corp’s quoted price sits in the lower half of its reported 52-week range, 46.99% below the high.
€18.65-€0.05 (-0.27%)
Boiron S.A.’s quoted price sits in the lower half of its reported 52-week range, 42.17% below the high.
£0.04-£0.00 (-6.25%)
Allergy Therapeutics plc’s quoted price sits in the lower half of its reported 52-week range, 69.01% below the high.
SEK 19.00-SEK 0.14 (-0.73%)
Swedencare AB (publ)’s quoted price sits in the lower half of its reported 52-week range, 52.32% below the high.
$0.23+$0.00 (+0.55%)
Elite Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.78% below the high.
€0.54-€0.01 (-1.09%)
AB Science S.A.’s quoted price sits in the lower half of its reported 52-week range, 66.34% below the high.
